| Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination DA Zaharoff, CJ Rogers, KW Hance, J Schlom, JW Greiner Vaccine 25 (11), 2085-2094, 2007 | 408 | 2007 |
| Localized interleukin-12 for cancer immunotherapy KG Nguyen, MR Vrabel, SM Mantooth, JJ Hopkins, ES Wagner, ... Frontiers in immunology 11, 575597, 2020 | 249 | 2020 |
| Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation F Lohr, DY Lo, DA Zaharoff, K Hu, X Zhang, Y Li, Y Zhao, MW Dewhirst, ... Cancer research 61 (8), 3281-3284, 2001 | 166 | 2001 |
| The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells B Koppolu, DA Zaharoff Biomaterials 34 (9), 2359-2369, 2013 | 149 | 2013 |
| Controlling chitosan-based encapsulation for protein and vaccine delivery B prasanth Koppolu, SG Smith, S Ravindranathan, S Jayanthi, ... Biomaterials 35 (14), 4382-4389, 2014 | 145 | 2014 |
| Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12 DA Zaharoff, BS Hoffman, HB Hooper, CJ Benjamin Jr, KK Khurana, ... Cancer research 69 (15), 6192-6199, 2009 | 139 | 2009 |
| Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery DA Zaharoff, RC Barr, CY Li, F Yuan Gene therapy 9 (19), 1286-1290, 2002 | 121 | 2002 |
| Intratumoral immunotherapy of established solid tumors with chitosan/IL-12 DA Zaharoff, KW Hance, CJ Rogers, J Schlom, JW Greiner Journal of immunotherapy 33 (7), 697-705, 2010 | 106 | 2010 |
| Chitosan solution enhances the immunoadjuvant properties of GM-CSF DA Zaharoff, CJ Rogers, KW Hance, J Schlom, JW Greiner Vaccine 25 (52), 8673-8686, 2007 | 87 | 2007 |
| In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines MJ Heffernan, DA Zaharoff, JK Fallon, J Schlom, JW Greiner Biomaterials 32 (3), 926-932, 2011 | 86 | 2011 |
| Nonlinear dependence of hydraulic conductivity on tissue deformation during intratumoral infusion S McGuire, D Zaharoff, F Yuan Annals of biomedical engineering 34, 1173-1181, 2006 | 84 | 2006 |
| Nanotheranostics of Circulating Tumor Cells, Infections and Other Pathological Features in Vivo JW Kim, EI Galanzha, DA Zaharoff, RJ Griffin, VP Zharov Molecular pharmaceutics 10 (3), 813-830, 2013 | 76 | 2013 |
| Mechanistic analysis of electroporation-induced cellular uptake of macromolecules DA Zaharoff, JW Henshaw, B Mossop, F Yuan Experimental Biology and Medicine 233 (1), 94-105, 2008 | 72 | 2008 |
| Effect of chitosan properties on immunoreactivity S Ravindranathan, BP Koppolu, SG Smith, DA Zaharoff Marine drugs 14 (5), 91, 2016 | 58 | 2016 |
| Exercise enhances vaccine-induced antigen-specific T cell responses CJ Rogers, DA Zaharoff, KW Hance, SN Perkins, SD Hursting, J Schlom, ... Vaccine 26 (42), 5407-5415, 2008 | 58 | 2008 |
| Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer SG Smith, BP Koppolu, S Ravindranathan, SL Kurtz, L Yang, MD Katz, ... Cancer immunology, immunotherapy 64, 689-696, 2015 | 54 | 2015 |
| Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice CJ Rogers, D Berrigan, DA Zaharoff, KW Hance, AC Patel, SN Perkins, ... The Journal of nutrition 138 (1), 115-122, 2008 | 50 | 2008 |
| Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis JLN Vo, L Yang, SL Kurtz, SG Smith, B Koppolu, S Ravindranathan, ... Oncoimmunology 3 (12), e968001, 2014 | 45 | 2014 |
| Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer SG Smith, JL Baltz, BP Koppolu, S Ravindranathan, K Nguyen, ... OncoImmunology 6 (1), e1259050, 2017 | 44 | 2017 |
| Electric fields in tumors exposed to external voltage sources: implication for electric field-mediated drug and gene delivery BJ Mossop, RC Barr, JW Henshaw, DA Zaharoff, F Yuan Annals of biomedical engineering 34, 1564-1572, 2006 | 39 | 2006 |
